Member Info for Top.trader

Very encouraging reading. People are waking up to this judging by the uptick in price of late

Have any drugs on the activ trials been up rated to the next tier or given early use approval yet? Would be interesting to know as if they have we have got a benchmark and if not at least we know that we aren’t lagging behind.

Lol the smug feeling didn’t last should have kept it to myself

I suppose all it shows is the institutional investor confidence that the share price should be 88p plus which the market has reacted to accordingly? Does seem odd for dilution to be reacted to in this way though but I’ll take it and feeling smug about recently topping up

Also looks like someone took approximately £1million worth of shares at 173.5 you’d have to think it’s a buy not a sell! Something brewing hopefully

It does seem strange for it to have dropped so much. A sell off on a spike after good news is understandable but the only ‘spike’ today was barely 2%. I want to buy more but not sure whether it’s worth waiting a few days to see if it goes lower. I brought in at 1.10 and have been buying more ever since was expecting 1.40/1.50 on good results but that hasn’t quite gone to plan. Still a good long term hold and not at all worried yet

Just seen an interview with the prime minister saying that anyone can be tested with a free lateral flow test from this Friday. Huge for ours and Excalibur’s deal!

Apps like trading 212 have no fees as they are included in the slightly inflated price so it could be people using these kind of apps

2 juicy 120k buys just gone through at 41.175

Seems like the market has overreacted to this news. Purely sounds like teething problems, debating topping up today.

I’m not sure whether the price will stagnate with no news or as more people digest the rns properly they will realise that it is not the terrible news that the share price appears to show it to be.

Please god be the RNS something first option lol

Unfortunately there was no information regarding timescales for the pilot. You would have to think it is going to be carried out reasonably quickly though as it is obviously a vital product for reopening business, sport and hospitality so I should think there is a very keen eye on it.

That would be immense if we managed to make a deal but surely our patents will not cover the use of nasal inhalers for vaccine aswell? I was under the impression it was for the delivery of mabs that we have the patent for correct me if I’m wrong.

Was being lazy earlier asking on here lol but found this. From nov 2020 crohns trial rns:

Recently, Tiziana announced positive results from its Phase 1 study showing that oral treatment with Foralumab was well-tolerated in healthy volunteers, with no drug-related safety issues even at the highest dose of 5 mg2

Just read the licensing rns again.

Oxford, U.K. 09 February 2021: Sensyne Health plc (LSE: SENS) ("Sensyne" or the "Company" or the "Group"), the UK Clinical AI company, today announces that it has signed an exclusive licence and development agreement with Excalibur Healthcare Services Limited ("Excalibur") to apply Sensyne's MagnifEye system for use with Excalibur's proprietary lateral flow rapid diagnostic tests across a range of indications including its COVID-19 antigen test currently being marketed in the UK and across Europe

‘Exclusive license and development agreement’

Could be taken many ways, are we the exclusive provider for Ai for reading Excalibur’s test? Or are they the exclusive user of our Ai?

I’m sure there will be clarification in the not so distant future if we do get the go ahead from public health England.

I think this alone is the easiest way to see the value that Tiziana is sat on purely in the inhaler technology.

It would be fantastic if we can treat covid with our products but even if it doesn’t materialise we are sat on a technology goldmine the price difference between an iv treatment and ours must be astronomical - whether we go the takeover route or bring the product to market ourself the true value will be realised at some point in future. Whether it is a quick gain or a long term hold the value of the patents does not change

Looks like we are onto a winner

I see they have seen a 70% reduction in deaths using there Mab ****tail. Doses between 300mg and 2000mg administered via iv I believe.

Does anyone know what mg dosages our treatment is offered in to put into perspective the low cost of our treatment compared to iv administered.

It also speaks volumes that we were able to attract a top dog from regeneron when they were on the brink of landing great results in their p3. Hopefully our p2 will go well then we may get fast tracked onto the activ 2!

Looking good today, a lot of fairly large buys going through, the steady rise back towards 20p continues.

I have held shares in sensyne health for a fair while who work alongside Excalibur to provide the ai for reading the lateral flow tests. I am hoping and praying that a collaboration takes place between catenae Excalibur and sensyne to form a catch all app that shows vaccination and test status. Such a great opportunity up for grabs I hope we can pull it off.